Thermo Fisher Scientific (TMO) Stock Price

Thermo Fisher Scientific Price

NYSE·CLOSED
588.29USD-14.72 (-2.47 %)
Market closed

Over the last 19 years Thermo Fisher Scientific grew revenue by 13.8% annually, reaching 44.56 B USD. Earnings per share have grown at 22.4% per year over the last 19 years. For Thermo Fisher Scientific, the net margin of 15.1% is down versus 19.7% a few years ago. At today's price the dividend yield works out to roughly 0.29%. The payout ratio is around 10% of earnings. The dividend has grown at 9.3% per year over the past 13 years. The consensus 12-month price target for Thermo Fisher Scientific is 683.40 USD, about 16.2% above where the stock trades today. Of 33 analysts, 27 rate the stock a buy — an overall Buy consensus. The stock trades about 34% above its 52-week low.

Thermo Fisher Scientific stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Thermo Fisher Scientific over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Thermo Fisher Scientific stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Thermo Fisher Scientific's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Thermo Fisher Scientific Stock Price History
DateThermo Fisher Scientific Price
8/14/2026588.29 USD
8/12/2026603.01 USD
8/11/2026605.00 USD
8/10/2026593.92 USD
8/7/2026594.00 USD
8/6/2026580.02 USD
8/5/2026577.10 USD
8/4/2026566.04 USD
8/3/2026574.03 USD
7/31/2026574.30 USD
7/30/2026576.77 USD
7/29/2026579.83 USD
7/27/2026567.02 USD
7/23/2026572.32 USD
7/22/2026526.46 USD
7/21/2026523.46 USD
7/20/2026526.23 USD
7/17/2026532.48 USD
7/16/2026543.19 USD
7/15/2026535.29 USD
7/14/2026534.07 USD
7/13/2026530.40 USD
7/10/2026527.05 USD
7/9/2026524.71 USD
7/8/2026510.27 USD
7/7/2026516.62 USD
7/6/2026512.32 USD
7/2/2026523.44 USD
7/1/2026513.33 USD
6/30/2026501.36 USD
6/29/2026502.17 USD
6/26/2026513.03 USD
6/25/2026505.75 USD
6/24/2026492.20 USD
6/23/2026469.35 USD
6/22/2026459.64 USD
6/18/2026464.36 USD
6/17/2026469.70 USD
6/16/2026471.20 USD
6/15/2026469.73 USD
6/12/2026476.55 USD
6/11/2026474.86 USD
6/10/2026487.60 USD
6/9/2026494.07 USD
6/8/2026469.63 USD
6/5/2026475.84 USD
6/4/2026484.73 USD
6/3/2026472.71 USD
6/2/2026486.35 USD
6/1/2026492.02 USD
5/29/2026489.36 USD
5/28/2026478.11 USD
5/27/2026449.34 USD
5/26/2026448.45 USD
5/22/2026445.16 USD
5/21/2026450.57 USD
5/20/2026444.15 USD
5/19/2026447.81 USD
5/18/2026442.00 USD
5/15/2026438.34 USD
5/14/2026448.21 USD
5/13/2026446.03 USD
5/12/2026459.30 USD
5/11/2026452.60 USD
5/8/2026465.00 USD
5/7/2026474.46 USD
5/6/2026472.95 USD
5/5/2026466.76 USD
5/4/2026462.60 USD
5/1/2026469.21 USD
4/30/2026478.96 USD
4/29/2026466.26 USD
4/28/2026470.22 USD
4/27/2026468.04 USD
4/24/2026469.71 USD
4/23/2026466.70 USD
4/22/2026513.98 USD
4/21/2026524.57 USD
4/20/2026526.02 USD
4/17/2026526.60 USD
4/16/2026516.00 USD
4/15/2026531.67 USD
4/14/2026527.22 USD
4/13/2026514.23 USD
4/10/2026496.11 USD
4/9/2026500.46 USD
4/8/2026503.46 USD
4/7/2026489.50 USD
4/6/2026488.19 USD
4/2/2026489.90 USD
4/1/2026494.54 USD
3/31/2026491.53 USD
3/30/2026480.05 USD
3/27/2026473.36 USD
3/26/2026488.85 USD
3/25/2026490.77 USD
3/24/2026490.29 USD
3/23/2026478.12 USD
3/20/2026478.27 USD
3/19/2026470.21 USD
3/18/2026470.21 USD
3/17/2026473.20 USD
3/16/2026470.00 USD
3/13/2026464.37 USD
3/12/2026475.89 USD
3/11/2026495.72 USD
3/10/2026500.08 USD
3/9/2026509.97 USD
3/6/2026504.01 USD
3/5/2026518.84 USD
3/4/2026512.69 USD
3/3/2026508.10 USD
3/2/2026508.58 USD
2/27/2026521.11 USD
2/26/2026511.56 USD
2/25/2026513.68 USD
2/24/2026515.60 USD
2/23/2026516.44 USD
2/20/2026510.93 USD
2/19/2026515.12 USD
2/18/2026513.56 USD
2/17/2026501.59 USD
2/13/2026504.82 USD
2/12/2026509.82 USD
2/11/2026527.17 USD
2/10/2026539.80 USD
2/9/2026546.76 USD
2/6/2026542.83 USD
2/5/2026542.36 USD
2/4/2026565.22 USD
2/3/2026570.09 USD
2/2/2026581.77 USD
1/30/2026579.00 USD
1/29/2026592.16 USD
1/28/2026609.01 USD
1/27/2026623.91 USD
1/26/2026626.62 USD
1/23/2026625.98 USD
1/22/2026639.46 USD
1/21/2026636.31 USD
1/20/2026619.01 USD
1/16/2026619.21 USD
1/15/2026624.65 USD
1/14/2026621.83 USD
1/13/2026607.08 USD
1/12/2026615.45 USD
1/9/2026618.87 USD
1/8/2026606.50 USD
1/7/2026610.01 USD
1/6/2026620.72 USD
1/5/2026611.20 USD
1/2/2026592.51 USD
12/31/2025579.45 USD
12/30/2025583.45 USD
12/29/2025585.07 USD
12/26/2025580.74 USD
12/24/2025579.12 USD
12/23/2025579.94 USD
12/22/2025575.70 USD
12/19/2025567.83 USD
12/18/2025562.39 USD
12/17/2025562.56 USD
12/16/2025570.17 USD
12/15/2025575.91 USD
12/12/2025572.28 USD
12/11/2025578.90 USD
12/10/2025574.01 USD
12/9/2025563.07 USD
12/8/2025568.21 USD
12/5/2025572.77 USD
12/4/2025575.24 USD
12/3/2025580.45 USD
12/2/2025580.37 USD
12/1/2025585.15 USD
11/28/2025590.83 USD
11/26/2025593.25 USD
11/25/2025597.78 USD
11/24/2025586.07 USD
11/21/2025587.48 USD
11/20/2025572.74 USD
11/19/2025573.79 USD
11/18/2025576.03 USD
11/17/2025567.16 USD
11/14/2025578.71 USD
11/13/2025580.13 USD
11/12/2025588.02 USD
11/11/2025586.49 USD
11/10/2025576.35 USD
11/7/2025572.41 USD
11/6/2025570.01 USD
11/5/2025567.64 USD
11/4/2025565.24 USD
11/3/2025564.88 USD
10/31/2025567.39 USD
10/30/2025556.22 USD
10/29/2025558.31 USD
10/28/2025557.63 USD
10/27/2025563.78 USD
10/24/2025572.51 USD
10/23/2025571.91 USD
10/22/2025567.20 USD
10/21/2025557.99 USD
10/20/2025543.84 USD
10/17/2025538.93 USD
10/16/2025536.78 USD
10/15/2025527.87 USD
10/14/2025525.83 USD
10/13/2025524.58 USD
10/10/2025523.01 USD
10/9/2025534.68 USD
10/8/2025536.19 USD
10/7/2025539.17 USD
10/6/2025543.95 USD
10/3/2025543.33 USD
10/2/2025524.96 USD
10/1/2025530.73 USD
9/30/2025485.02 USD
9/29/2025462.04 USD
9/28/2025462.04 USD
9/25/2025464.24 USD
9/24/2025459.22 USD
9/23/2025469.75 USD
9/22/2025474.99 USD
9/19/2025479.59 USD
9/18/2025481.10 USD
9/17/2025472.64 USD
9/16/2025480.74 USD
9/15/2025474.46 USD
9/12/2025479.47 USD
9/11/2025491.41 USD
9/10/2025476.54 USD
9/9/2025482.41 USD
9/8/2025487.65 USD
9/5/2025492.61 USD
9/4/2025489.49 USD
9/3/2025484.55 USD
9/2/2025487.53 USD
8/29/2025492.73 USD
8/28/2025489.74 USD
8/27/2025488.12 USD
8/26/2025488.48 USD
8/25/2025490.75 USD
8/22/2025500.00 USD
8/21/2025483.76 USD
8/20/2025494.81 USD
8/19/2025498.29 USD
8/18/2025487.54 USD
8/15/2025489.02 USD
Access this data via the Eulerpool API
Get Free API Key

Thermo Fisher Scientific Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
42.86 B USD
6.86 B USD
6.00 B USD
Jan 1, 2024
42.88 B USD
7.66 B USD
6.34 B USD
Jan 1, 2025
44.56 B USD
8.11 B USD
6.74 B USD
Jan 1, 2026 (e)
47.86 B USD
9.65 B USD
9.50 B USD
Jan 1, 2027 (e)
50.32 B USD
10.15 B USD
10.40 B USD
Jan 1, 2028 (e)
53.38 B USD
10.77 B USD
11.40 B USD
Jan 1, 2029 (e)
56.58 B USD
11.42 B USD
12.84 B USD
Jan 1, 2030 (e)
58.50 B USD
11.81 B USD
14.42 B USD

Thermo Fisher Scientific Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 15, 2026, 4:22 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITB USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
16.9718.2720.9224.3625.5432.2239.2144.9242.8642.8844.5647.8650.3253.3856.5858.50
0.457.7214.4716.454.8626.1421.7114.55-4.580.053.917.425.146.076.003.40
46.2046.9646.2745.1144.4149.7550.0742.3340.9841.3437.6637.6637.6637.6637.6637.66
7.848.589.6810.9911.3416.0319.6319.0117.5617.7316.7818.0218.9520.1021.3122.03
2.492.863.273.874.267.909.388.536.867.668.119.6510.1510.7711.4211.81
14.7015.6415.6215.9016.6724.5123.9118.9816.0017.8718.2020.1620.1620.1820.1820.18
1.982.022.232.943.706.387.736.956.006.346.749.5010.4011.4012.8414.42
4.282.3310.0932.0425.8072.4821.18-10.03-13.745.676.3540.949.529.6612.5612.31
0.600.600.600.680.760.881.041.201.401.561.721.882.152.46––
–––13.3311.7615.7918.1815.3816.6711.4310.269.3014.3614.42––
402.40397.00405.00405.00402.00400.00398.00393.00388.00383.00377.00377.00377.00377.00377.00377.00
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Thermo Fisher Scientific generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Thermo Fisher Scientific retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Thermo Fisher Scientific's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Thermo Fisher Scientific has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Thermo Fisher Scientific's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Thermo Fisher Scientific stock margins

The Thermo Fisher Scientific margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Thermo Fisher Scientific. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Thermo Fisher Scientific.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
50.07 %
23.91 %
19.70 %
Jan 1, 2022
42.33 %
18.98 %
15.47 %
Jan 1, 2023
40.98 %
16.00 %
13.99 %
Jan 1, 2024
41.34 %
17.87 %
14.77 %
Jan 1, 2025
37.66 %
18.20 %
15.12 %
Jan 1, 2026 (e)
37.66 %
20.16 %
19.84 %
Jan 1, 2027 (e)
37.66 %
20.16 %
20.66 %
Jan 1, 2028 (e)
37.66 %
20.18 %
21.36 %

Thermo Fisher Scientific Stock Revenue, EBIT, Earnings per Share

The Thermo Fisher Scientific earnings per share therefore indicates how much revenue Thermo Fisher Scientific has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
98.52 USD
23.56 USD
19.41 USD
Jan 1, 2022
114.29 USD
21.69 USD
17.68 USD
Jan 1, 2023
110.46 USD
17.68 USD
15.45 USD
Jan 1, 2024
111.96 USD
20.01 USD
16.54 USD
Jan 1, 2025
118.19 USD
21.51 USD
17.87 USD
Jan 1, 2026 (e)
126.62 USD
25.60 USD
25.12 USD
Jan 1, 2027 (e)
133.13 USD
26.92 USD
27.51 USD
Jan 1, 2028 (e)
141.22 USD
28.58 USD
30.17 USD

Thermo Fisher Scientific business model & stock analysis

Thermo Fisher Scientific Inc - A global market leader

Thermo Fisher Scientific SWOT Analysis

Strengths

Thermo Fisher Scientific Inc offers a diverse portfolio of products, including scientific instruments, consumables, reagents, software, and services. This extensive range allows them to cater to the needs of various industries and customers, providing a strong competitive advantage.

Thermo Fisher Scientific Inc has established a strong brand reputation in the scientific research and healthcare sectors. Their commitment to innovation, quality, and reliability has earned the trust of customers worldwide, boosting their market position and customer loyalty.

Thermo Fisher Scientific Inc operates globally and has a well-established distribution network. Their wide geographic presence allows them to reach customers worldwide efficiently and effectively, contributing to their market share dominance and revenue growth.

Weaknesses

Thermo Fisher Scientific Inc heavily relies on continuous research and development activities for new product development and improvement. Any disruption or failure in R&D efforts could impact their ability to innovate and maintain a competitive edge in the market.

Thermo Fisher Scientific Inc operates in highly regulated industries, such as healthcare and pharmaceuticals. Changes in government regulations and policies can significantly impact their operations, requiring compliance adjustments that may incur additional costs or restrict market access.

Opportunities

The advancement of precision medicine presents an opportunity for Thermo Fisher Scientific Inc as it aligns with their expertise in genomics, proteomics, and other precision research areas. The increasing demand for personalized healthcare solutions can drive the adoption of their products and services.

Thermo Fisher Scientific Inc can capitalize on the rapid growth of emerging markets, such as Asia-Pacific and Latin America. By expanding their presence in these regions and adapting to local market needs, they can tap into new customer segments and boost their revenue streams.

Threats

Thermo Fisher Scientific Inc faces fierce competition from other global players and niche market entrants. The competitive landscape poses a threat to their market share, pricing power, and customer acquisition, necessitating consistent innovation, marketing, and strategic efforts to maintain their competitive position.

Fluctuations in the global economy, currency exchange rates, and geopolitical events can impact Thermo Fisher Scientific Inc's financial performance. Economic uncertainties, recessions, or downturns may reduce customer spending on scientific research and healthcare, affecting their sales and profitability.

Thermo Fisher Scientific Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Thermo Fisher Scientific Employees
Details
Date
Thermo Fisher Scientific Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Thermo Fisher Scientific Segments

Thermo Fisher Scientific Revenue by Segment (1/4)

  • Max

Product revenues
Service revenues
Details
Date
Product
Product revenues
Service revenues
Service
Jan 1, 2024
0.00 USD
25.03 B USD
17.85 B USD
0.00 USD
Jan 1, 2025
0.00 USD
25.97 B USD
18.59 B USD
0.00 USD

Thermo Fisher Scientific Revenue by Segment (2/4)

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Details
Date
Consumables
Instruments
Jan 1, 2024
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD

Thermo Fisher Scientific Revenue by Segment (3/4)

  • Max

Consumables
Instruments
Details
Date
Consumables
Instruments
Jan 1, 2024
17.59 B USD
7.45 B USD
Jan 1, 2025
18.66 B USD
7.30 B USD

Thermo Fisher Scientific Revenue by Segment (4/4)

  • Max

Laboratory Products and Biopharma Services
Life Sciences Solutions
Analytical Instruments
Specialty Diagnostics
Details
Date
Laboratory Products and Biopharma Services
Life Sciences Solutions
Analytical Instruments
Specialty Diagnostics
Jan 1, 2024
23.00 B USD
8.16 B USD
7.27 B USD
4.45 B USD
Jan 1, 2025
23.82 B USD
8.78 B USD
7.35 B USD
4.60 B USD

Thermo Fisher Scientific Revenue by Region

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

North America
Other Countries
United States
All Other Countries
Europe
Asia-Pacific
Asia Pacific
China
Other regions
Germany
United Kingdom
Japan
Details
Date
North America
Other Countries
United States
All Other Countries
Europe
Asia-Pacific
Asia Pacific
China
Other regions
Germany
United Kingdom
Japan
Jan 1, 2018
12.14 B USD
0.00 USD
11.63 B USD
10.23 B USD
6.22 B USD
0.00 USD
5.25 B USD
2.50 B USD
750.00 M USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
12.90 B USD
0.00 USD
12.37 B USD
10.42 B USD
6.36 B USD
0.00 USD
5.52 B USD
2.75 B USD
764.00 M USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
17.08 B USD
0.00 USD
16.44 B USD
12.99 B USD
8.28 B USD
0.00 USD
5.82 B USD
2.80 B USD
1.03 B USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
19.66 B USD
0.00 USD
18.91 B USD
16.86 B USD
11.13 B USD
0.00 USD
7.22 B USD
3.44 B USD
1.20 B USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2022
24.59 B USD
17.30 B USD
23.82 B USD
0.00 USD
10.76 B USD
8.12 B USD
0.00 USD
3.79 B USD
1.44 B USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
22.76 B USD
20.84 B USD
22.01 B USD
0.00 USD
10.74 B USD
7.87 B USD
0.00 USD
0.00 USD
1.48 B USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
22.50 B USD
21.12 B USD
21.76 B USD
0.00 USD
10.86 B USD
7.96 B USD
0.00 USD
0.00 USD
1.56 B USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
23.03 B USD
22.32 B USD
22.24 B USD
0.00 USD
11.83 B USD
8.10 B USD
0.00 USD
0.00 USD
1.60 B USD
0.00 USD
0.00 USD
0.00 USD

Thermo Fisher Scientific Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Thermo Fisher Scientific historical P/E ratio, EBIT multiple, and P/S ratio

Thermo Fisher Scientific annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Thermo Fisher Scientific shares outstanding

The number of shares of Thermo Fisher Scientific was 377 M in 2025. This indicates how many shares Thermo Fisher Scientific is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
398.00 M Stocks
Jan 1, 2022
393.00 M Stocks
Jan 1, 2023
388.00 M Stocks
Jan 1, 2024
383.00 M Stocks
Jan 1, 2025
377.00 M Stocks
Jan 1, 2026 (e)
377.00 M Stocks
Jan 1, 2027 (e)
377.00 M Stocks
Jan 1, 2028 (e)
377.00 M Stocks

Thermo Fisher Scientific stock splits

In Thermo Fisher Scientific's history, there have been no stock splits.

Thermo Fisher Scientific Dividend History

16 years of dividend payments · 8 consecutive increases

YearAnnual DividendYoY ChangePayments
20260.94USDYTD—2×
Mar 13, 20260.47USD↑ 9.3%1/2
Jun 15, 20260.47USD 0.0%2/2
20251.72USD↑ 10.3%4×
Mar 14, 20250.43USD↑ 10.3%1/4
Jun 13, 20250.43USD 0.0%2/4
Sep 15, 20250.43USD 0.0%3/4
Dec 15, 20250.43USD 0.0%4/4
20241.56USD↑ 11.4%4×
20231.40USD↑ 16.7%4×
20221.20USD↑ 15.4%4×
20211.04USD↑ 18.2%4×
20200.88USD↑ 15.8%4×
20190.76USD↑ 11.8%4×
20180.68USD↑ 13.3%4×
20170.60USD 0.0%4×

Thermo Fisher Scientific dividend history and estimates

In 2025, Thermo Fisher Scientific paid a dividend amounting to 1.72 USD. Dividend means that Thermo Fisher Scientific distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
1.04 USD
0.00 USD
Jan 1, 2022
1.20 USD
0.00 USD
Jan 1, 2023
1.40 USD
0.00 USD
Jan 1, 2024
1.56 USD
0.00 USD
Jan 1, 2025
1.72 USD
0.00 USD
Jan 1, 2026 (e)
0.94 USD
0.94 USD
Jan 1, 2027 (e)
0.00 USD
2.15 USD
Jan 1, 2028 (e)
0.00 USD
2.46 USD

Thermo Fisher Scientific dividend payout ratio

In 2025, Thermo Fisher Scientific had a payout ratio of 9.63%. The payout ratio indicates the percentage of the company's profits that Thermo Fisher Scientific distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
5.36 %
Jan 1, 2022
6.79 %
Jan 1, 2023
9.06 %
Jan 1, 2024
9.43 %
Jan 1, 2025
9.63 %
Jan 1, 2026 (e)
7.48 %
Jan 1, 2027 (e)
7.81 %
Jan 1, 2028 (e)
8.15 %

Current Thermo Fisher Scientific forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
3.47 %
Buy
81.82 % (27)
Hold
18.18 % (6)
Sell
0.00 % (0)
12M Price Target
683.40
Last Price
595.89
Currency
USD
12M Return Potential
14.69 %
LTM Return
0 %

Thermo Fisher Scientific Analyst Rating Actions

DateFirmActionRatingReliability
7/27/2026
Piper Sandler
Piper Sandler
MaintainedNeutral51
7/27/2026
Morgan Stanley
Morgan Stanley
MaintainedOverweight60
7/24/2026
RBC Capital
RBC Capital
MaintainedSector Perform52
7/24/2026
Barclays
Barclays
MaintainedOverweight33
7/6/2026
Evercore ISI Group
Evercore ISI Group
MaintainedOutperform62
6/3/2026
HSBC
HSBC
DowngradeBuyHold–
5/8/2026
Wells Fargo
Wells Fargo
MaintainedOverweight56
4/24/2026
Stifel
Stifel
MaintainedBuy–
4/24/2026
Baird
Baird
MaintainedOutperform–
4/14/2026
Barclays
Barclays
MaintainedOverweight33

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Thermo Fisher Scientific Earnings Calls

2025
2024

Thermo Fisher Scientific Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
7/23/20265.77USD-11.82 BUSD-2026 Q2
4/23/20265.29USD-10.95 BUSD-2026 Q1
1/29/20266.51USD-12.07 BUSD-2025 Q4
4/24/20245.02USD-10.42 BUSD-2024 Q1
1/30/20245.70USD-10.83 BUSD-2023 Q4
7/26/20235.76USD-11.08 BUSD-2023 Q2
4/26/20235.58USD-10.71 BUSD-2023 Q1
1/31/20235.25USD-10.56 BUSD-2022 Q4
10/26/20224.86USD-10.06 BUSD-2022 Q3
7/28/20225.04USD-10.12 BUSD-2022 Q2
...

EESG©

Eulerpool ESG Scorecard© for the Thermo Fisher Scientific stock

88/100
99
Environment
99
Social
65
Governance
E

Environment

20
Scope 1 - Direct Emissions331,463
Scope 2 - Indirect emissions from purchased energy427,904
Scope 3 - Indirect emissions within the value chain11,320,351
Total CO₂ emissions759,367
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees48
Percentage of women in management—
Percentage of Asian employees14.76
Share of Asian management12.53
Percentage of Hispanic/Latino employees8.57
Hispano/Latino Management share5.94
Percentage of Black employees11.78
Black Management Share6.63
Percentage of white employees61.63
White Management Share72.22
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Thermo Fisher Scientific shareholder structure

% Name
8.04952%
BLACKROCK, INC.
BLACKROCK, INC.
6.42350%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
4.42637%
STATE STREET CORP
STATE STREET CORP
2.87395%
MORGAN STANLEY
MORGAN STANLEY
2.85091%
FMR LLC
FMR LLC
2.22431%
GEODE CAPITAL MANAGEMENT, LLC
GEODE CAPITAL MANAGEMENT, LLC
...

Thermo Fisher Scientific Beneficial Ownership Filings (SEC 13D/G)

Free Float
99.7%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
15.20%
Wildcat Acquisition Holdings (UK) Limited
Wildcat Acquisition Holdings (UK) Limited
SEC ↗
15.20%
Thermo Fisher Scientific Powder US Holdings Corp.
Thermo Fisher Scientific Powder US Holdings Corp.
SEC ↗
15.20%
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
SEC ↗
15.20%
PPD, Inc.
PPD, Inc.
SEC ↗
15.20%
Pharmaceutical Product Development, LLC
Pharmaceutical Product Development, LLC
SEC ↗
15.20%
Jaguar Holding Company I, LLC
Jaguar Holding Company I, LLC
SEC ↗
15.20%
Jaguar Holding Company II
Jaguar Holding Company II
SEC ↗
15.20%
Eagle Holding Company II, LLC
Eagle Holding Company II, LLC
SEC ↗
7.90%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
7.89%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗

Thermo Fisher Scientific Executives and Management Board

21 members · avg. age 59 · 29 % women

MC

Mr. Marc Casper (57)

Chairman of the Board, President, Chief Executive Officer · since 2001

30.45 M USD

Management

ML

Mr. Michel Lagarde (51)

Chief Operating Officer, Executive Vice President

12.78 M USD
GP

Mr. Gianluca Pettiti (46)

Executive Vice President · since 2021

11.34 M USD
SW

Mr. Stephen Williamson (58)

Chief Financial Officer, Senior Vice President

11.09 M USD
FL

Mr. Frederick Lowery (54)

Executive Vice President

8.53 M USD
MB

Mr. Michael Boxer (63)

Senior Vice President, General Counsel

3.12 M USD
LB

Ms. Lisa Britt (56)

Chief Human Resources Officer, Senior Vice President

2.89 M USD

Board of Directors

SS

Mr. Scott Sperling (67)

Lead Independent Director

406,520.00 USD
NC

Mr. Nelson Chai (59)

Independent Director

365,836.00 USD
DW

Mr. Dion Weisler (57)

Independent Director

354,020.00 USD
DS

Dr. Debora Spar (61)

Independent Director

353,336.00 USD
TJ

Dr. Tyler Jacks (64)

Director

345,836.00 USD
RC

Ms. Ruby Chandy (63)

Independent Director

340,836.00 USD

Thermo Fisher Scientific Supply Chain

Thermo Fisher Scientific Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
30 companies
#Nameβ 1YTrend
1
Horizon Therapeutics Public Limited Company
Customer
0.76
0.22
0.88
0.91
0.61
0.95
—
2
Castle Bioscien
Customer
0.63
0.63
0.28
0.50
0.35
0.90
0.51
3
DKSH Holding
Customer
0.46
0.51
0.05
0.09
0.34
0.90
0.28
4
Bio-Techne
Supplier
0.44
0.72
0.91
0.94
0.62
0.87
0.77
5
Telix Pharmaceuticals
Supplier·Customer
0.45
0.10
0.74
0.81
0.66
0.84
—
#Nameβ 1YTrend
1
NanoEnTek
0.92
0.48
-0.67
-0.69
-0.41
—
-1.24
2
Quanterix Corporation
Supplier
0.71
0
-0.76
-0.39
-0.01
—
—
3
Pluralsight, Inc.
Supplier
0.59
0.67
0.69
0.72
0.72
—
—
4
Windtree Therapeutics, Inc.
Customer
0.50
0.24
-0.55
-0.49
-0.36
—
—
5
Nabriva Therapeutics
Customer
0.46
0.73
-0.65
-0.82
-0.34
-0.79
—

Frequently asked questions about Thermo Fisher Scientific

Thermo Fisher Scientific Inc is a renowned company that operates in the scientific research and healthcare sector. The business model of Thermo Fisher Scientific Inc centers around providing a wide range of products, services, and solutions to enable scientific discoveries and advancements. The company offers innovative instruments, consumables, software, and services to enable scientists and researchers to address complex challenges in various fields such as life sciences, pharmaceutical, biotechnology, and more. Thermo Fisher Scientific Inc also focuses on providing analytical instruments, reagents, consumables, software, and services to support healthcare professionals in diagnosing and treating various diseases. With its comprehensive offerings, Thermo Fisher Scientific Inc strives to empower its customers to make the world healthier, cleaner, and safer.

Thermo Fisher Scientific Inc is primarily active in the life sciences, healthcare, and research industries.

The main competitors of Thermo Fisher Scientific Inc in the market include Agilent Technologies, Danaher Corporation, and Illumina Inc.

Thermo Fisher Scientific Inc is a renowned company with a rich history and background. Established in 2006 through the merger of Thermo Electron and Fisher Scientific, it is now a global leader in serving the scientific research, pharmaceutical, and healthcare industries. With a diverse portfolio of innovative products and services, Thermo Fisher Scientific enables its customers to make important discoveries, enhance diagnostics, and improve overall patient care. The company's commitment to providing advanced solutions and expertise has propelled its growth, establishing it as a trusted partner in the scientific community. Today, Thermo Fisher Scientific continues to drive innovation and shape the future of scientific research and healthcare worldwide.

Thermo Fisher Scientific Inc has achieved several significant milestones throughout its history. The company completed the acquisition of Life Technologies Corporation in 2014, which expanded its offerings in the life sciences field. Additionally, Thermo Fisher Scientific has made strides in advancing precision medicine and genetic research, developing innovative solutions for healthcare professionals. The company has also received recognition for its initiatives in sustainability, being included in the Dow Jones Sustainability World Index multiple times. Furthermore, Thermo Fisher Scientific has consistently reported robust financial performance, driving growth and shareholder value.

Thermo Fisher Scientific Inc is primarily present in multiple countries and regions worldwide. The company operates in North America, including the United States and Canada, where it has a strong presence. Additionally, Thermo Fisher Scientific Inc has a significant presence throughout Europe, with operations in countries such as the United Kingdom, Germany, France, and Spain. The company also serves customers in Asia, including China, India, Japan, and South Korea. Thermo Fisher Scientific Inc is expanding its footprint in emerging markets like Latin America and Africa, aiming to provide its products and services to customers globally.

Thermo Fisher Scientific Inc represents values centered on innovation, integrity, and customer focus. As a global leader in serving science, the company is committed to enabling their customers to make the world a healthier, cleaner, and safer place. Thermo Fisher Scientific Inc strives to provide cutting-edge technologies and solutions in the fields of life sciences, healthcare, and diagnostics. With a strong emphasis on research and development, their corporate philosophy aims to improve human health and wellbeing through constant innovation and collaboration with their customers. Thermo Fisher Scientific Inc is dedicated to delivering reliable and high-quality products and services that contribute to scientific advancements worldwide.

Analysts currently set an average price target of 678.16 USD for the Thermo Fisher Scientific stock (median: 683.40 USD), implying +13.8 % versus the latest price. The consensus is based on 33 analyst ratings.

Thermo Fisher Scientific Analyst Price Targets 2026

33 analysts currently rate the Thermo Fisher Scientific stock: 27 recommend buying, 6 holding and 0 selling. For 2026, analysts expect Thermo Fisher Scientific to generate revenue of 47.86 B USD and earnings per share of 25.19 USD.

Thermo Fisher Scientific Analyst Price Targets 2026

Converted at the current exchange rate, the Thermo Fisher Scientific share trades at 508.64 EUR (588.29 USD).

The Thermo Fisher Scientific share (TMO) is listed on 10 stock exchanges, including: NYSE (TMO), XETRA (TN8.DE), Frankfurt (TN8.F), München (TN8.MU), Düsseldorf (TN8.DU), London (0R0H.L), London (0R0H.L), SIX (Zürich) (TFS.SW).

Thermo Fisher Scientific Inc is a global leading company in the field of laboratory analysis and diagnostic devices. The business model of Thermo Fisher Scientific Inc is based on providing solutions to businesses, government agencies, hospitals, research institutions, and many other customers. The company offers a variety of products and services in different business areas, including life sciences, diagnostics, analytics, and laboratory products. Thermo Fisher Scientific Inc has a strong presence in over 50 countries and serves customers in various industries and regions. Its wide range of products and services includes solutions for scientists and researchers in developing new drugs, improving healthcare, and protecting the environment. Additionally, the company offers diagnostic solutions for laboratories and physicians to enhance patient care, as well as specialized products and solutions for material analysis. Thermo Fisher Scientific Inc also provides a wide range of laboratory products and offers services such as system integration, validation, qualification, training, and support. With continuous research and development, acquisitions, and collaboration with customers, the company aims to expand and enhance its expertise in the field of science and technology.

The expected revenue of Thermo Fisher Scientific is 47.86 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Thermo Fisher Scientific is 9.50 B USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Thermo Fisher Scientific is currently 23.36. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Thermo Fisher Scientific stock.

The price-to-sales ratio (P/S) of Thermo Fisher Scientific is currently 4.63. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Thermo Fisher Scientific stock.

The Eulerpool Quality Score for Thermo Fisher Scientific is 5/10.

The ISIN of Thermo Fisher Scientific is US8835561023. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Thermo Fisher Scientific is 857209. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Thermo Fisher Scientific is TMO. The ticker symbol is used to trade Thermo Fisher Scientific shares on the stock exchange.

Over the past 12 months, Thermo Fisher Scientific paid a dividend of 1.72 USD . This corresponds to a dividend yield of about 0.29 %. For the coming 12 months, Thermo Fisher Scientific is expected to pay a dividend of 2.15 USD.

The current dividend yield of Thermo Fisher Scientific is 0.29 %.

Thermo Fisher Scientific pays a dividend, distributed in the months of , , , .

Thermo Fisher Scientific paid dividends every year for the past 14 years.

For the upcoming 12 months, dividends amounting to 2.15 USD are expected. This corresponds to a dividend yield of 0.36 %.

Thermo Fisher Scientific is assigned to the 'Health' sector.

In the year 2025, Thermo Fisher Scientific distributed 1.56 USD as dividends.

The dividends of Thermo Fisher Scientific are distributed in USD.

All fundamentals and in-depth analysis of Thermo Fisher Scientific

Our stock analysis for Thermo Fisher Scientific stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Thermo Fisher Scientific. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Thermo Fisher Scientific Stock
Thermo Fisher Scientific Revenue→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific Net Income→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific P/E→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific P/S→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific EBIT→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific Dividend→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific Directors Dealings→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific Stocks→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific Market capitalization→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific Debt→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific Liabilities→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific Equity→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific AAQS→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific Employees→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific ROE→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific ROA→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific ROCE→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific News→
Thermo Fisher Scientific Stock
Thermo Fisher Scientific Analyst Price Targets→

Health Stocks

Thermogenesis HoldingsTherma BrightThird Age Health ServicesTheriva BiologicsThomson Medical GroupTheravance BiopharmaThonburi Healthcare Group PCLTherapeuticsMDThonburi Medical Centre PCLTheranexusThor Medical ATheralink TechnologiesAll Stocks A–Z →